SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?


To: John Swingle who wrote (3669)4/24/2001 10:39:47 AM
From: devonian  Respond to of 3725
 
Their major competition is probably GE and Siemens imaging groups, both of which are strong in similar MRI technology. However, Imatrons ultrafast technology is reportedly vastly better due the superior speed of the scanners. Consider the heart which doesn't stop moving; Imatron's scans much faster than the heart moves, so you get a substantially clearer picture, and better diagnostics as a result. GE and Siemans have slower technology and need rely more on software to "unblurr" the image due to the heart's movement. They are several years behind Imatron. However, GE and Siemens have far superior marketing (not an Imatron strong point). GECC does often provide financing necessary for Imatron machines, and Immelt (the new GE CEO is well aware of Imatron's machines - he comes from the medical imaging side remember). The success will depend on which dominates; technology or marketing. However, as the medical community (ie cardiologists) become more educated on the relative merits, the data will support Imatron pretty clearly. This education process is still in early stages and many cardiologists are reluctant to move to a technology which reduces their gravy train of invasive medicine.

As to capacity, can't tell ya, but my sense is, that is the least of they're worries. Getting a stronger sales force is #1.

This really is a fantastic technology; 30 seconds and you know where your heart health's at (and soon your colon and lungs). Whether its a great investment is debatable because they face three goliaths; GE, reluctant cardiologists and cheap, short-sighted insurers.

Worth futher investigation. Also, get a scan - it's well worth it.

JMO, Dev



To: John Swingle who wrote (3669)4/24/2001 12:39:35 PM
From: TA2K  Read Replies (1) | Respond to of 3725
 
Imatron is actively ramping up production capacity.

This is a good little company.